Impact of Food and Drug Administration Regulatory Approach on the 0/2-Hour Algorithm for Rapid Triage of Suspected Myocardial Infarction

Circ Cardiovasc Qual Outcomes. 2019 Jan;12(1):e005188. doi: 10.1161/CIRCOUTCOMES.118.005188.

Karin Wildi^{1

2

3}, Thomas Nestelberger¹, Desiree Wussler^{1

4}, Jasper Boeddinghaus^{1

4

5}, Patrick Badertscher^{1

6}, Luca Koechlin^{1

7}, Paul Duwe¹, Maria Rubini Gimenez¹, Raphael Twerenbold¹, Christian Mueller¹

¹ Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology (K.W., T.N., D.W., J.B., P.B., L.K., P.D., M.R.G., R.T., C.M.), University Hospital Basel, University of Basel, Switzerland.
² Critical Care Research Group, the Prince Charles Hospital, Brisbane, Australia (K.W.).
³ University of Queensland, Brisbane, Australia (K.W.).
⁴ Department of Internal Medicine (D.W., J.B.), University Hospital Basel, University of Basel, Switzerland.
⁵ Department of Cardiology and Angiology II, University Heart Center Freiburg-Bad Krozingen, Germany (J.B.).
⁶ Department of Cardiology, University of Illinois at Chicago (P.B.).
⁷ Department of Cardiac Surgery (L.K.), University Hospital Basel, University of Basel, Switzerland.

No abstract available

Keywords: United States Food and Drug Administration; electrocardiography; myocardial infarction; troponin.

Publication types